Header Logo

Kirk Packo

Concepts (173)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retinal Diseases
4
2021
9
1.040
Why?
Fundus Oculi
2
2021
2
0.800
Why?
Gardner Syndrome
1
2021
1
0.780
Why?
Retinal Pigment Epithelium
1
2021
2
0.780
Why?
Endophthalmitis
4
2010
8
0.510
Why?
Vitrectomy
10
2010
15
0.450
Why?
Tomography, Optical Coherence
5
2021
16
0.300
Why?
Drug Implants
1
2006
12
0.280
Why?
Ganciclovir
1
2006
27
0.280
Why?
Macula Lutea
4
2016
7
0.280
Why?
Foreign-Body Migration
1
2006
20
0.280
Why?
Visual Acuity
11
2016
46
0.260
Why?
Antiviral Agents
1
2006
136
0.250
Why?
Retinoschisis
2
2014
2
0.230
Why?
Retina
4
2014
12
0.230
Why?
Macular Edema
2
2015
7
0.210
Why?
Sutures
2
2021
42
0.200
Why?
Adenomatous Polyposis Coli Protein
1
2021
1
0.200
Why?
DNA Mutational Analysis
1
2021
57
0.190
Why?
Lenses, Intraocular
1
2021
4
0.190
Why?
Laser Coagulation
2
2015
5
0.170
Why?
Mutation
1
2021
399
0.170
Why?
Eye Proteins
2
2016
8
0.170
Why?
Fluorescein Angiography
9
2016
12
0.160
Why?
Retinal Perforations
2
2010
2
0.150
Why?
Humans
24
2021
29852
0.150
Why?
Glucocorticoids
2
2015
69
0.140
Why?
Fibrinolytic Agents
2
2010
57
0.140
Why?
Retinal Detachment
4
2002
8
0.140
Why?
Male
18
2021
15871
0.140
Why?
Eye Diseases, Hereditary
1
2016
1
0.140
Why?
Choroid Diseases
1
2016
3
0.140
Why?
Retinal Degeneration
1
2016
4
0.140
Why?
Mutation, Missense
1
2016
22
0.130
Why?
Chloride Channels
1
2016
10
0.130
Why?
Adult
11
2021
8748
0.130
Why?
Diabetic Retinopathy
1
2015
6
0.130
Why?
Angiogenesis Inhibitors
1
2015
18
0.130
Why?
Macular Degeneration
2
2005
3
0.130
Why?
Dog Diseases
1
1995
18
0.130
Why?
Multimodal Imaging
1
2014
20
0.120
Why?
Light Coagulation
2
1995
2
0.120
Why?
Myopia
1
2013
2
0.110
Why?
Middle Aged
14
2014
9963
0.100
Why?
Anesthesia, Intravenous
1
1991
8
0.100
Why?
Candidiasis
1
1991
17
0.100
Why?
Propofol
1
1991
17
0.100
Why?
Blindness
2
2016
14
0.090
Why?
Vitreous Detachment
1
2010
1
0.090
Why?
Acanthamoeba
1
2010
2
0.090
Why?
Acanthamoeba Keratitis
1
2010
2
0.090
Why?
Amebiasis
1
2010
3
0.090
Why?
Fibrinolysin
1
2010
5
0.090
Why?
Eye Infections, Parasitic
1
2010
4
0.090
Why?
Keratoplasty, Penetrating
1
2010
6
0.090
Why?
Choroid
2
1989
3
0.090
Why?
Peptide Fragments
1
2010
97
0.090
Why?
Neovascularization, Pathologic
2
1989
57
0.090
Why?
Female
15
2014
16430
0.080
Why?
Scleral Buckling
4
1998
4
0.080
Why?
Iatrogenic Disease
1
1989
26
0.080
Why?
Niacin
1
2008
2
0.080
Why?
Cataract Extraction
1
2008
4
0.080
Why?
Hypolipidemic Agents
1
2008
22
0.080
Why?
Follow-Up Studies
6
2016
1859
0.070
Why?
Cytomegalovirus Retinitis
1
2006
4
0.070
Why?
Aged
11
2014
9621
0.070
Why?
Device Removal
1
2006
86
0.070
Why?
Choroidal Neovascularization
1
2005
2
0.070
Why?
Visual Field Tests
1
2005
3
0.070
Why?
Postoperative Complications
7
2004
957
0.070
Why?
Polymerase Chain Reaction
2
2016
166
0.060
Why?
Retinal Hemorrhage
1
2004
3
0.060
Why?
Retinitis Pigmentosa
1
2004
2
0.060
Why?
Semiconductors
1
2004
4
0.060
Why?
Tissue Plasminogen Activator
1
2004
42
0.060
Why?
Electrodes, Implanted
1
2004
47
0.060
Why?
Prosthesis Implantation
1
2004
35
0.060
Why?
Laser Therapy
2
1997
13
0.060
Why?
Aged, 80 and over
6
2014
4930
0.050
Why?
Vitreoretinopathy, Proliferative
1
2002
2
0.050
Why?
Lens Capsule, Crystalline
1
2002
6
0.050
Why?
Lens, Crystalline
1
2002
32
0.050
Why?
Treatment Outcome
5
2015
3561
0.050
Why?
Chiropractic
1
1980
2
0.050
Why?
Vitreous Body
2
2010
7
0.050
Why?
Suture Techniques
1
2021
141
0.040
Why?
Retinal Vessels
2
2016
3
0.040
Why?
Ophthalmologic Surgical Procedures
1
1998
2
0.040
Why?
Propranolol
1
1998
13
0.040
Why?
Anti-Anxiety Agents
1
1998
41
0.040
Why?
Adrenergic beta-Antagonists
1
1998
42
0.040
Why?
Injections
2
2010
59
0.040
Why?
Hospital Charges
1
1997
20
0.040
Why?
Retrospective Studies
4
2014
3325
0.040
Why?
Drug Therapy, Combination
1
1997
245
0.030
Why?
Anxiety
1
1998
157
0.030
Why?
Tremor
1
1998
143
0.030
Why?
Bestrophins
1
2016
1
0.030
Why?
RNA Splice Sites
1
2016
3
0.030
Why?
Iris
1
2016
3
0.030
Why?
Exons
1
2016
38
0.030
Why?
Ischemia
1
2016
27
0.030
Why?
Atrophy
1
2016
106
0.030
Why?
Lipids
1
2015
36
0.030
Why?
Lens Implantation, Intraocular
2
2008
5
0.030
Why?
Vascular Endothelial Growth Factor A
1
2015
69
0.030
Why?
Fluorocarbons
1
1995
16
0.030
Why?
Cryosurgery
1
1995
20
0.030
Why?
Blood Glucose
1
2015
112
0.030
Why?
Microsurgery
1
1995
40
0.030
Why?
Dogs
1
1995
261
0.030
Why?
Blood Pressure
1
2015
252
0.030
Why?
Internship and Residency
1
1998
213
0.030
Why?
Patient Selection
1
2015
234
0.030
Why?
Anti-Bacterial Agents
1
1997
401
0.030
Why?
Double-Blind Method
2
2010
522
0.030
Why?
Remission, Spontaneous
1
2013
10
0.030
Why?
Recurrence
2
1997
355
0.030
Why?
Intraoperative Complications
2
2004
71
0.030
Why?
Adolescent
5
2002
2334
0.030
Why?
Suction
1
1992
41
0.030
Why?
Antifungal Agents
1
1991
36
0.020
Why?
Contact Lenses, Hydrophilic
1
2010
2
0.020
Why?
Eye Enucleation
1
2010
2
0.020
Why?
Antiprotozoal Agents
1
2010
12
0.020
Why?
Chemotherapy, Adjuvant
1
2010
95
0.020
Why?
Microscopy, Confocal
1
2010
116
0.020
Why?
Preoperative Care
1
2010
135
0.020
Why?
Risk Factors
1
2015
2467
0.020
Why?
Pseudophakia
1
2008
1
0.020
Why?
Prednisolone
1
2008
7
0.020
Why?
Choroiditis
1
1988
2
0.020
Why?
Sclera
2
1998
2
0.020
Why?
Combined Modality Therapy
2
2004
379
0.020
Why?
Child
3
1998
1379
0.020
Why?
Animals
1
1995
4637
0.020
Why?
Photography
1
2005
17
0.020
Why?
False Positive Reactions
1
2005
34
0.020
Why?
Evoked Potentials, Visual
1
2004
4
0.010
Why?
Electroretinography
1
2004
2
0.010
Why?
Silicon
1
2004
4
0.010
Why?
Visual Fields
1
2004
5
0.010
Why?
Prone Position
1
2004
29
0.010
Why?
Diagnosis, Differential
1
2005
399
0.010
Why?
Pressure
1
2004
61
0.010
Why?
Safety
1
2004
48
0.010
Why?
Electric Stimulation
1
2004
84
0.010
Why?
Predictive Value of Tests
1
2005
532
0.010
Why?
Sensitivity and Specificity
1
2005
558
0.010
Why?
Visual Perception
1
2004
50
0.010
Why?
Young Adult
1
2010
1969
0.010
Why?
Recombinant Proteins
1
2004
258
0.010
Why?
Reproducibility of Results
1
2005
803
0.010
Why?
Pilot Projects
1
2004
403
0.010
Why?
Silicone Oils
1
2002
2
0.010
Why?
New Zealand
1
1980
13
0.010
Why?
Prospective Studies
1
2005
1824
0.010
Why?
Cross-Over Studies
1
1998
80
0.010
Why?
Placebos
1
1998
82
0.010
Why?
Hospitals, Community
1
1997
14
0.010
Why?
Hospitals, University
1
1997
40
0.010
Why?
Cost Savings
1
1997
35
0.010
Why?
Cost-Benefit Analysis
1
1997
143
0.010
Why?
Quality of Health Care
1
1998
138
0.010
Why?
United States
1
1980
2346
0.010
Why?
Pigment Epithelium of Eye
1
1988
2
0.000
Why?
Eye Foreign Bodies
1
1987
1
0.000
Why?
Methods
1
1986
17
0.000
Why?
Acyclovir
1
1986
5
0.000
Why?
Retinitis
1
1986
3
0.000
Why?
Necrosis
1
1986
27
0.000
Why?
Acute Disease
1
1986
225
0.000
Why?
Packo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (173)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_